Clinical Trial Update: Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial tested whether combining hybrid closed-loop insulin therapy with verapamil can preserve beta-cell function in people with new-onset Type 1 diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Verapamil (verapamil)

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Type1 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2024-11-27